1. Introduction {#sec1}
===============

Within the last decade, our understanding of the importance of hematopoietic cells in obese adipose tissue and how this regulates inflammation has grown tremendously [@bib1]. In lean animals and humans, resident adipose tissue macrophages (ATM) help maintain tissue homeostasis. But macrophages are also particularly important in regulation of whole-body inflammation [@bib2], [@bib3], [@bib4], [@bib5]. During metabolic insult, including obesity or fasting, the resident ATMs become outnumbered by macrophages recruited for tissue maintenance and repair [@bib6], [@bib7]. The significance of metabolism in macrophage differentiation is emphasized by recent findings that anti-inflammatory macrophages require fatty acid oxidation, whereas pro-inflammatory macrophages switch to glycolytic metabolism [@bib8], [@bib9], [@bib10], [@bib11], [@bib12]. Importantly, much of what we know about macrophage substrate switches that are required for cellular function, metabolism, and inflammatory status has relied on *in vitro* experiments with specific cytokine skewing of macrophages; whether these paradigms persist *in vivo* is less clear.

Fatty acid oxidation in macrophages is reliant on the transport of fatty acids across mitochondrial membrane through conjugation of acyl groups to carnitine, which is regulated by carnitine acyltransferases [@bib13]. Carnitine palmitoyltransferase 1 and 2 (CPT1, CPT2) conjugate carnitine to long-chain fatty acids and are required for fatty acid oxidation [@bib13]. Carnitine O-octanoyltransferase (CrOT) and carnitine acetyltransferase (CrAT) conjugate medium-chain and short-chain acyl-CoA to carnitine, respectively [@bib13]. CrAT is localized primarily within the mitochondrial matrix and catalyzes both the addition and the removal of carnitine from acetyl-CoA [@bib14], facilitating the efflux of mitochondrial acetyl-CoA and buffering the intracellular pools of acetyl-CoA and carnitine. Consistent with an important role of fatty acid oxidation in macrophages, CPT1, CPT2, Crat and Crot are abundantly expressed in macrophages [@bib15]. Interestingly, the CrAT activity is reduced during obesity and aging, leading to impaired glycemic control [@bib16], [@bib17]. Notably, muscle-specific deletion of CrAT was shown to reduce exercise performance [@bib18] and exacerbated metabolic dysregulation in HFD mice [@bib19]. Moreover, CrAT-deficient muscle accumulates long-chain acyl-carnitines, an indicator of incomplete β-oxidation [@bib19]. CrAT-mediated acetylcarnitine production and efflux regulates glucose homeostasis and alleviates product inhibition of pyruvate dehydrogenase (PDH) that controls glycolysis and glucose oxidation [@bib16]. Given the critical role of each of these mechanisms in macrophage function and inflammatory status [@bib9], [@bib10], we hypothesized that ablation of CrAT from macrophages would promote macrophage-mediated inflammation during nutrient stress. Surprisingly, we found that loss of CrAT expression in myeloid-lineage cells had no impact on total body glucose metabolism or adipose tissue inflammation in conditions of high-fat diet mediated nutrient overload. Deficiency of CrAT-mediated nutrient stress sensing in macrophages did not impact NLRP3 inflammasome activation or differentiation into M1/M2-like polarization. Furthermore, macrophage expression of CrAT was also not required to mount a successful fasting response nor impacted LPS-induced inflammation, which is reliant on increased lipolysis as well as increased glycolysis. Our findings reveal that, unlike muscle cells, macrophages have unique metabolic substrate requirement machinery where CrAT expression in is dispensable for regulating adipose tissue inflammation and whole body glucose metabolism under conditions of metabolic stress.

2. Research design and methods {#sec2}
==============================

2.1. Animals {#sec2.1}
------------

Crat^fl/fl^ mice were generously provided by Dr. Randall Mynatt (Pennington Biomedical Research Center [@bib19]). Crat^fl/fl^ were bred to LysM-Cre (B6.129P2-Lyz2^tm1(cre)/fo^/J, Jackson Labs) to ablate Crat in all myeloid lineage cells, henceforth referred to as Crat^Mϕ−/−^. Cre-negative Crat^fl/fl^ littermate controls were used in all experiments. All experiments were performed in compliance with the Yale Institutional Animal Care and Use Committee.

2.2. *In vitro* assays {#sec2.2}
----------------------

Bone marrow-derived macrophages (BMDM) were generated as previously described [@bib20]. For NLRP3 inflammasome activation, BMDM were primed with LPS (1 μg/mL) for 4 h, followed by treatment with ATP (5 mM, 1 h), sphingosine (50 μM, 1 h), monosodium urate crystals (MSU, 250 μg/mL, 5 h), silica (200 μg/mL, 5 h), ceramide (C6, 80 μg/mL, 6 h), or palmitate (200 μM, 18 h). For macrophage polarization, BMDM were skewed towards M1 (LPS + IFNγ 20 ng/mL), M2 (IL-4 10 ng/mL), or left untreated (M0) for 24 h. Real-time metabolism was measured in M2-skewed BMDM using a Seahorse metabolic flux analyzer (Seahorse, Agilent). BMDM were polarized for 24 h prior to mitochondrial stress test (etomoxir 40 μM, oligomycin 1.5 μM, FCCP 0.75 μM, Rotenone 2 μM, Antimycin A 2 μM). Fatty acid oxidation was calculated by dividing OCR after etomoxir injection by baseline OCR. Spare respiratory capacity was calculated by subtracting baseline OCR from maximum OCR after FCCP injection.

2.3. Gene expression {#sec2.3}
--------------------

mRNA was isolated in Trizol using the Qiagen RNeasy kit. cDNA was transcribed using iScript cDNA synthesis kit (Bio-Rad). Gene expression was measured by RT-PCR by ΔΔC~t~ method and expressed relative to Gapdh.

2.4. Protein expression {#sec2.4}
-----------------------

Protein expression was evaluated by SDS-PAGE western blot. IL-1β (Genetex), Caspase-1 (generously provided by Genentech), CRAT (Proteintech) and β-Actin (Cell Signaling) were visualized by chemiluminescence.

2.5. *In vivo* metabolic assays {#sec2.5}
-------------------------------

High-fat diet (HFD, 60%) feeding was initiated at 6 weeks old, and mice were fed ad libitum for 12 weeks. ATM were isolated by magnetic F4/80-positive selection (LifeTech). Mice were fasted for 12 h (glucose tolerance test, 0.4 g/kg bw glucose i.p.) or 4 h (insulin tolerance test, 0.8 U/kg bw i.p.). For fasting experiments, mice were fasted 24 h, beginning at 10am. For endotoxemia experiments, mice were challenged with LPS (25 μg i.p.) and euthanized 4 h later for analysis of inflammation.

2.6. Flow cytometry {#sec2.6}
-------------------

Visceral and subcutaneous adipose tissue were digested in Collagenase I as previously described [@bib21] to isolate the stromal vascular fraction (SVF). SVF was stained with live/dead viability dye (Invitrogen), CD3, B220, CD11b, F4/80, CD11c (all from eBioscience), and CD206 (Biolegend) to gate T cells, B cells, and macrophage subsets. Data were acquired on a custom LSR II (BD Bioscience) and analyzed in FlowJo (Treestar).

2.7. Statistical analysis {#sec2.7}
-------------------------

Statistical analyses as described in the figure legends were performed in Prism (GraphPad). P \< 0.05 was considered significant for all experiments.

3. Results {#sec3}
==========

3.1. CrAT-deficient macrophages have normal *in vitro* polarization {#sec3.1}
-------------------------------------------------------------------

ATM are a major source of adipose tissue inflammation, driven in part by a macrophage metabolic switch from fatty acid oxidation to glycolysis [@bib1], [@bib6]. CrAT was previously identified to regulate metabolic flexibility in muscle and whole body glucose homeostasis [@bib17], [@bib18], [@bib19]. To understand the role of CrAT in macrophage function, we tested whether genetic ablation of CrAT from bone marrow derived macrophages (BMDM) altered their activation status and polarization *in vitro*. Crat gene deletion was verified by qPCR ([Figure 1](#fig1){ref-type="fig"}A) and western blot ([Figure 1](#fig1){ref-type="fig"}B) and did not alter expression of acyl-transferase family member Cpt1a ([Figure 1](#fig1){ref-type="fig"}C) or plasma membrane lipid scavenger CD36 ([Figure 1](#fig1){ref-type="fig"}D), both of which facilitate macrophage fatty acid oxidation and M2-like alternative activation [@bib8]. Crat-deficient BMDM were polarized *in vitro* towards M1 or M2 fates and expression of canonical lineage-specific genes, iNOS (Nos2) and Arginase 1 (Arg1) were measured. Crat^Mϕ−/−^ and Crat^fl/fl^ cells had equal expression of iNOS ([Figure 1](#fig1){ref-type="fig"}E) and Arg1 ([Figure 1](#fig1){ref-type="fig"}F). In addition to M1/M2 polarization, activation of the NLRP3 inflammasome is a critical driver of adipose tissue inflammation and metabolic dysregulation [@bib22]. Importantly, equal caspase-1 activation and IL-1β secretion were observed in response to a variety of NLRP3 activators regardless of CrAT expression ([Figure 1](#fig1){ref-type="fig"}G). Because CRAT belongs to the acyltransferase enzyme family that controls fatty acid oxidation we also tested whether Crat deletion induced a functional deficiency in macrophage metabolism. We examined mitochondrial metabolism in M2-polarized BMDM because these cells are well known to upregulate and rely on fatty acid oxidation and mitochondrial metabolism [@bib8]. Although Crat-deficient BMDM had slightly elevated basal OXPHOS ([Figure 1](#fig1){ref-type="fig"}H), their reliance on fatty acid oxidation, probed by treatment with etomoxir, was equal to Crat-sufficient cells ([Figure 1](#fig1){ref-type="fig"}I). Spare respiratory capacity was also unaffected by Crat deletion ([Figure 1](#fig1){ref-type="fig"}J). We conclude that CrAT-deficient macrophages retain both pro-inflammatory and anti-inflammatory potential.

3.2. Myeloid CrAT ablation has no effect on adipose tissue inflammation during obesity {#sec3.2}
--------------------------------------------------------------------------------------

So far, the data showed CrAT expression is dispensable for inflammatory differentiation *in vitro*. However, the local macrophage phenotype within adipose tissue environment *in vivo* is far more complicated than can be modeled *in vitro*. Therefore, Crat^Mϕ−/−^ mice were fed HFD to induce obesity and metabolic dysregulation and were compared to Crat^fl/fl^ littermate controls. Only male mice were tested because females are not susceptible to HFD-induced metabolic dysregulation [@bib23]. Mice gained weight equally during HFD feeding regardless of myeloid Crat expression ([Figure 2](#fig2){ref-type="fig"}A). Chow-fed Crat^Mϕ−/−^ mice exhibited normal fasting blood glucose levels ([Figure 2](#fig2){ref-type="fig"}B) and glucose tolerance ([Figure 2](#fig2){ref-type="fig"}C). Obese mice fed HFD exhibited typical elevated fasting blood glucose ([Figure 2](#fig2){ref-type="fig"}D) and neither glucose tolerance ([Figure 2](#fig2){ref-type="fig"}E) nor insulin sensitivity ([Figure 2](#fig2){ref-type="fig"}F) were altered by Crat ablation. To determine whether Crat expression regulates adipose tissue leukocytosis, we analyzed T cells, B cells, and macrophage subsets within the white adipose tissue after 12 weeks of HFD feeding (representative gating strategy shown in [Figure 2](#fig2){ref-type="fig"}G). Myeloid Crat expression was dispensable for immune cell infiltration into white adipose tissue ([Figure 2](#fig2){ref-type="fig"}H--M). As expected, macrophages, particularly pro-inflammatory CD11c^+^ subsets, increased in visceral and subcutaneous adipose tissue during HFD ([Figure 2](#fig2){ref-type="fig"}J,M), and this was not regulated by Crat. We further assessed M1/M2-like gene expression within isolated ATM from visceral fat. While gene expression analysis confirmed Crat ablation in ATM *in vivo* ([Figure 2](#fig2){ref-type="fig"}N), Arg1 expression was increased in ATM ([Figure 2](#fig2){ref-type="fig"}O) while pro-inflammatory cytokines IL-1β, iNOS, and TNFα were somewhat elevated, although these differences did not reach statistical significance ([Figure 2](#fig2){ref-type="fig"}P--R). The modest variations in ATM compared to BMDM ([Figure 1](#fig1){ref-type="fig"}E,F) probably reflect the more complicated and lipid-rich adipose tissue environment compared to culture media. Overall, these data show that in conditions of diet-induced obesity, Crat expression within the myeloid compartment does not regulate inflammation or glycemic control.

3.3. CrAT expression in myeloid cells does not regulate fasting-induced lipolysis {#sec3.3}
---------------------------------------------------------------------------------

In contrast to the detrimental pro-inflammatory functions of ATM during obesity, ATM also have an important protective role in tissue remodeling and homeostasis [@bib24], [@bib25]. During periods of increased lipolysis, macrophages are recruited to adipose tissue and phagocytize excess lipids to protect tissue integrity [@bib26].We next asked whether CrAT might regulate ATM function during fasting-induced negative energy balance that requires increased mitochondrial fatty acid oxidation. After 24 h fasting, a time point previously reported to induce macrophage recruitment to adipose tissue and phagocytosis of lipids [@bib26], all mice had similar weight loss ([Figure 3](#fig3){ref-type="fig"}A) and fasting blood glucose ([Figure 3](#fig3){ref-type="fig"}B) regardless of sex or genotype. During fasting, limited glucose availability induces a metabolic switch towards fatty acid oxidation to sustain energetic demands. Fatty acid oxidation requires fatty acid transport into the mitochondria, ultimately producing acetyl-CoA, which is then converted into ketone bodies for export to the brain and heart as an alternative energy substrate. Myeloid Crat expression did not regulate production of β-hydroxybutyrate (BHB, [Figure 3](#fig3){ref-type="fig"}C), the most abundant ketone body produced during fasting. Glycerol release from adipose tissue explants, a measure of lipolysis, was also unaffected by Crat expression in ATM in both visceral ([Figure 3](#fig3){ref-type="fig"}D) and subcutaneous ([Figure 3](#fig3){ref-type="fig"}E) adipose depots. Altogether, this suggests that CrAT does not regulate the ATM response to fasting-induced lipolysis.

3.4. Myeloid-specific CrAT expression does not regulate inflammatory response during LPS-induced lipolysis {#sec3.4}
----------------------------------------------------------------------------------------------------------

In addition to metabolic homeostasis, macrophages are important mediators of acute inflammation. LPS injections (i.p.) were used to model acute endotoxemia. Of note, LPS causes lethal inflammation that is fueled by glycolysis [@bib27]. Therefore, we examined whether myeloid Crat expression regulated the inflammatory response after LPS administration *in vivo*. As expected, the LPS treatment reduced blood glucose concentrations ([Figure 4](#fig4){ref-type="fig"}A) and induced upregulation of TNFα, IL-1β, and IL-18 in visceral adipose tissue ([Figure 4](#fig4){ref-type="fig"}B) and spleen ([Figure 4](#fig4){ref-type="fig"}C) 4 h post-injection. Thus, similar to a chronic HFD metabolic challenge, deficiency of Crat in macrophages did not impact the ability of animals to mount acute inflammatory response.

4. Discussion {#sec4}
=============

CrAT regulates the intracellular acetyl-CoA availability by enabling efflux of short-chain acyl-CoA from the mitochondria [@bib28]. Deletion of CrAT from smooth muscle has revealed important roles for CrAT in mitochondrial energy metabolism [@bib18], maintenance of the mitochondrial acetylated proteome [@bib28], and whole body glucose metabolism during HFD [@bib19]. Metabolic switch from fatty acid oxidation to glycolysis and byproducts of TCA cycle regulate macrophage inflammation [@bib8], [@bib9], [@bib10], [@bib11]. Acetyl-CoA is a critical intracellular metabolite poised to regulate many cellular processes, including transcription, post-translational modifications, and metabolism, but regulators of the acyl-CoA pool in macrophage inflammation has not been studied. In light of these findings, we hypothesized that CrAT deletion in myeloid cells would exaggerate adipose tissue inflammation and metabolic dysregulation. Remarkably, CrAT expression in all myeloid-lineage cells was dispensable for whole body glycemic regulation in response to a variety of metabolic challenges, including high-fat diet, fasting-induced lipolysis, and LPS-induced acute inflammation.

The balance between glycolytic metabolism and fatty acid oxidation regulates macrophage differentiation and inflammatory responses [@bib8]. Unlike CPT1a, CrAT does not directly regulate fatty acid oxidation, but its regulation of carbon efflux from the mitochondria during glucose overload facilitates metabolic flexibility, a characteristic likely important for macrophages given their diverse functions. The lack of any discernable phenotype after myeloid-specific CrAT ablation in obesity, fasting, or endotoxemia suggests macrophages (and other myeloid cells) do not rely on this regulatory pathway during metabolic stress. These results were surprising given the critical role of cellular metabolism in macrophage inflammation. Furthermore, the tissue-specific requirement (smooth muscle versus myeloid cells) of CrAT function under the same metabolic challenge (HFD) is striking. It is not clear why myeloid cells do not rely on CrAT to regulate inflammation and glycemic control during metabolic stress. It is possible that macrophages are equipped with alternative regulatory pathways that either (a) compensate for the function of CrAT, or (b) are prioritized over CrAT, thus leaving CrAT itself dispensable in macrophages. Alternatively, acetyl-CoA might be used or metabolized so rapidly in macrophages that CrAT is simply non-essential. Additionally, these pathways may be temporally regulated, which was not evaluated in our studies.

*In vitro* studies have revealed that fatty acid metabolism and inflammation are intimately linked in macrophages. However, the *in vivo* environments in which macrophages reside are far more complex than can be modeled *in vitro*, emphasizing the need for more thorough analyses of *in vivo* inflammatory models to fully understand the complicated and dynamic metabolic regulation of inflammation. In conclusion, our data highlight the importance of cell type-specific metabolic differences in whole body glycemic control. Our data also reveal the important finding that Crat-mediated mitochondrial efflux of acetyl-CoA is not intrinsically required by macrophages for their regulation of nutrient stress response and inflammation.
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![**Crat-deficient BMDM retain normal inflammatory potential**. Bone marrow-derived macrophages were stimulated *in vitro* to test the requirement of Crat expression for inflammatory activation. (A) Cre-mediated Crat deletion was verified by RT-PCR and (B) western blot. (C) Cpt1a and (D) CD36 gene expression were measured in unstimulated BMDM to validate Crat-specific deletion. BMDM were polarized towards M1-like or M2-like and (E) iNOS and (F) Arginase 1 gene expression were measured by RT-PCR. (G) Caspase-1 activation and IL-1β secretion were assessed culture supernatants and whole cell lysates by western blot. (H--J) Mitochondria oxidative phosphorylation metabolism in M2 BMDM was measured by Seahorse assay. (H) Mitochondrial stress test. (I) Relative fatty acid oxidation and (J) Spare respiratory capacity were calculated as described in methods. Statistical differences were calculated by unpaired two-tailed student\'s t-tests or 2-way ANOVA between genotypes. Data are pooled from 3 independent experiments and are expressed as mean ± SEM. Each symbol represents a sample pooled from at least 2 mice of indicated genotype. (F) Data are representative of 3 independent experiments, each pooled from at least n = 3 mice per genotype.](gr1){#fig1}

![**Crat expression in ATM does not regulate inflammation during obesity**. Obesity was induced in male mice by HFD feeding for 12 weeks. (A) Body weights were measured weekly after initiation of HFD, denoted by arrow. (B) Fasting blood glucose and (C) glucose tolerance were measured in chow-fed male mice after 12 h overnight fasting. (D) Fasting blood glucose, (E) glucose tolerance, and (F) insulin tolerance were measured in HFD-fed male mice. (G) Representative flow cytometry gating strategy of SVF of visceral adipose tissue. (H) Total cellularity, (I) abundance of immune cell populations and (J) macrophage subsets in visceral adipose tissue were analyzed by flow cytometry. (K) Total cellularity, (L) abundance of immune cell populations and (M) macrophage subsets in subcutaneous adipose tissue were analyzed by flow cytometry. (N--R) Gene expression in macrophages isolated from obese visceral adipose tissue was measured by RT-PCR and normalized to Gapdh. For all graphs, data were pooled from 2 independent cohorts, each with at least n = 5 mice/group, and are expressed as mean ± SEM. Each symbol represents an individual mouse. Statistical differences were calculated by two-way ANOVA for time-course analyses or unpaired two-tailed student\'s t-tests between genotypes.](gr2){#fig2}

![**Myeloid Crat expression does not regulate fasting-induced lipolysis response**. Systemic lipolysis responses were measured in male and female mice after 24 h fasting. (A) Body weights were measured pre- and post-fasting, and the percentage of body weight lost after fasting was calculated. (B) Blood glucose and (C) blood BHB levels were measured after 24 h fasting. Glycerol release from (D) visceral and (E) subcutaneous adipose tissue explants was measured after 24 h fasting to determine relative level of lipolysis. Statistical differences between genotypes were calculated by student\'s t-test for each sex. For all graphs, data were pooled from 3 independent experiments and are expressed as mean ± SEM. Each symbol represents an individual mouse.](gr3){#fig3}

![**Myeloid Crat expression does not regulate inflammatory response to acute endotoxemia**. Mice were injected with LPS i.p. and acute inflammatory response was assessed 4 h later. (A) Blood glucose was measured before and after LPS injection. (B, C) Induction of inflammatory genes was measured in visceral fat and spleen in sham and LPS-injected mice. Data are representative of 3 independent experiments. Each symbol represents an individual mouse. Statistical differences were calculated by (A) 2-way ANOVA comparing genotypes pre- and post-LPS, or (B,C) 1-way ANOVA comparing genotypes for each gene.](gr4){#fig4}
